Show an ad over header. AMP

I am the FIRST!!!

The blue wave threatening to crush Trump's re-election chances is growing

With 102 days until Election Day, the blue wave threatening to swamp President Trump's re-election chances keeps getting bigger and bigger.

Why it matters: We all know that anything can happen. But right now, every measurable trend is going against Trump — and with each day that passes, it gets increasingly harder for him to claw his way back.


The Cook Political Report on Friday flipped Florida from "toss-up" to "leans Democratic," citing the state's spiraling coronavirus outbreak.

  • That follows a Quinnipiac poll on Thursday that showed Joe Biden leading by 13 points in the Sunshine State. For context, Trump led Hillary Clinton by 3 points in the same poll in mid-July 2016.

Our thought bubble, from Axios White House editor Margaret Talev: Trump's re-election path has to go through Florida.

  • Without it, he's done.

The tsunami flows down-ballot: Charlie Cook and his team now like Democrats' chances to reclaim the Senate, shifting races in Arizona, Georgia and Iowa in their favor this week.

  • Cook also moved 20 House races toward Democrats.
  • Dave Wasserman, its House editor, said he couldn't recall a similarly sized shift for one party.

The big picture: Trump's net approval rating (-15) has remained remarkably consistent throughout his presidency, highlighting the difficulty he faces in trying to quickly turn around public opinion.

  • 538's Harry Enten noted on CNN this morning that, since 1940, incumbent presidents who were re-elected had an average net approval rating of +23.
  • Those who lost had an average net approval rating of -14.

The bottom line: The pandemic isn't going anywhere. And no matter what the president wants, it's going to define everything from here on out.

  • 102 days ago, the U.S. had 860,000 confirmed coronavirus cases (now 4 million), and Trump claimed "total" authority over ordering states to reopen.
  • Think of everything that's happened since.

regular 4 post ff

infinite scroll 4 pff

The world is watching the FDA's AstraZeneca decision

AstraZeneca's coronavirus vaccine took yet another public relations hit yesterday, when the European Medicines Agency announced that the shot is linked to blood clots, and they should be listed as a "very rare" side effect of the vaccine.

What we're watching: Even before the link was announced, the U.S. didn't need the AstraZeneca vaccine, based on its existing supply of other shots. But what the Food and Drug Administration decides to do about the vaccine — if the company seeks U.S. authorization — will likely have global ramifications.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
]> &lol4;